Scott Rocklage, Ph.D. is a Managing Partner of 5AM Ventures. He received his bachelors degree in Chemistry from the University of California and his Ph.D. in Chemistry from the Massachusetts Institude of Technology. Dr. Rocklage has over thirty years of management experience in healthcare. In the past, he served as Chairman and CEO of Cubist Pharmaceuticals and later CEO and President of Nycomed Salutar. He joined the Venture family in 2003 and only one year later was promoted to Managing Partner. It is thanks to his responsibility and dedication that three new drug applications were approved by the FDA. He has also helped to enter multiple people into interesting clinical trials and more information click here.
The idea for 5AM Ventures was created because the business revolves around company formation. Dr. Rocklage works with scientists, physicians and business-executives to form ideas for new medicines that do not yet exist. It is hard to fall into a routine in this business; one day he will be attending Board meetings and the next he is learning about progressive areas of life science. This fast paced environment is managed by his excellent time management, planning and prioritization skills. He believes it is important to remain loyal to the original 5AM Venture business plan and avoid distractions when new fads pop up in the industry and learn more about Scott.
Scott Rocklage looks forward to the future and recommends a certain degree of risk-taking in order to find success. Currently he is interested in the new ability to target specific genotypes and mutations which aids in treating cancer. Every day is a step closer to new advancements in fighting the disease and Dr. Rocklage is eager to help in these progressive steps toward the future and Scott’s lacrosse camp.